Festo V 250mg Injection

Festo‑V 250mg Injection contains fulvestrant, a hormonal anticancer medicine used in specialist treatment plans for certain hormone receptor-positive, advanced, or metastatic breast cancers. Fulvestrant attaches to oestrogen receptors and promotes their breakdown, reducing the ability of oestrogen to stimulate cancer-cell growth. It may be used alone or with other targeted anticancer medicines, depending on menopausal status, previous treatment, tumour characteristics, and the oncologist’s assessment. Festo‑V is administered as a slow, deep intramuscular injection into the buttock by a trained healthcare professional. Treatment commonly requires two 250mg injections to provide a 500mg dose, but the precise dose and schedule must be determined by the oncologist. Common adverse effects include injection-site pain, hot flushes, nausea, tiredness, headache, joint or muscle pain, and increased liver enzymes. Inform the oncology team about liver disease, bleeding disorders, low platelet levels, or anticoagulant treatment. Fulvestrant can harm an unborn baby; pregnancy must be avoided during treatment and for the recommended period afterward. Seek urgent medical attention for severe allergic reactions, unusual bleeding, chest pain, breathing difficulty, leg swelling, or symptoms of significant liver injury.

Price: Rs. 76925.00

• Manufacturer
  Al Habib Pharmaceutical
• Generic name
  Fulvestrant
• Pack size
  1 Box=2vials injection
• Availability
  In stock
• Prescription required
  Yes